News
Harvard Quietly Resolves Anti-Palestinian Discrimination Complaint With Ed. Department
News
Following Dining Hall Crowds, Harvard College Won’t Say Whether It Tracked Wintersession Move-Ins
News
Harvard Outsources Program to Identify Descendants of Those Enslaved by University Affiliates, Lays Off Internal Staff
News
Harvard Medical School Cancels Class Session With Gazan Patients, Calling It One-Sided
News
Garber Privately Tells Faculty That Harvard Must Rethink Messaging After GOP Victory
An important breakthrough in cancer research was announced Wednesday. Dr. Richard E. Wilson, associate professor of Surgery, was able to demonstrate the ability of the body's natural antibodies to reject cancer cells.
In August 1964, Wilson transplanted a kidney from a cancer victim to a patient. Then, in January 1966, he discovered that the transplant had induced in his patient the same form of cancer that had killed the kidney donor. Wilson discontinued the use of immunosuppressive drugs which had inhibited the patient's ability to reject the transplant by weakening the antibodies.
The patient's body responded by rejecting both the kidney and the cancer. Subsequently, after the drugs had been recontinued to allow a new operation, the cancer failed to reappear, indicating a complete cure.
The report, written by Wilson and five other doctors, appeared in The New gland Journal of Medicine.
Want to keep up with breaking news? Subscribe to our email newsletter.